Pediatrix Medical (MD) news
Recent news
Pediatrics Medical 2Q adj. EBITDA $76M, est. $73.9M
Pediatrix Medical Group, Inc. (NYSE: MD) reported adjusted EBITDA of $73.2 million for the second quarter of 2025, exceeding the estimated range of $73.9 million. The company attributed the strong performance to stable payor mix, improved collections, and effective operations management. Net…
AInvest Wire · Aug 4, 2026Pediatrics Medical Group - reaffirms FY2026 adj EBITDA outlook of $280 mln-$300 mln
Pediatrix Medical Group, Inc. (MD) has reaffirmed its FY2026 adjusted EBITDA outlook of $280 million to $300 million, as outlined in its recent earnings call . This guidance reflects the company’s continued focus on operational efficiency and service delivery across its neonatal and pediatric care…
AInvest Wire · Jul 15, 2026ImportantMicron Technology down 6.8%, AMD down 4.6%, Intel down 4.2%, Qualcomm down 3.5%, Marvell Technology down 5.8%
AInvest Wire · Jun 4, 2026ImportantMicron Technology down 5.7%, AMD down 3.6%, Intel down 3.8%, Qualcomm down 4%, Marvell Technology down 6.5%
AInvest Wire · Jun 4, 2026ImportantU.S. light vehicle total sales 1.5 mln in May - OMDIA
AInvest Wire · Jun 2, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.